In China, no easy way to get Pfizer’s COVID drug Paxlovid
By Sophie Yu and Martin Quin Pollard BEIJING (Reuters) – When Li’s 83-year-old father with diabetes started coughing and complaining of body aches last month, the Beijing resident became anxious about finding a treatment for COVID-19 in case his parent had caught the virus sweeping the city. He heard at that time that Pfizer’s anti-viral …
In China, no easy way to get Pfizer’s COVID drug Paxlovid Read More »










